At a meeting of the Trade-related Aspects of Intellectual Property Rights (TRIPS) Council on Tuesday, India and others submitted a text proposing that World Trade Organization (WTO) ministerial council be "extended mutatis mutandi for the production and supply of Covid-19 therapeutics and diagnostics". China and Singapore echoed the US' position for an extension of the deadline to decide the waiver at the meeting.
